107 related articles for article (PubMed ID: 5387171)
1. [Experience with a low dosage ovulation inhibitor].
Himmelsbach H
Med Monatsschr; 1969 Dec; 23(12):561-3. PubMed ID: 5387171
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on Ovostat--a combined oral contraceptive with a low dose of lynestrenol].
Rice-Wray E; Cervantes A
Geburtshilfe Frauenheilkd; 1974 May; 34(5):380-3. PubMed ID: 4603404
[TBL] [Abstract][Full Text] [Related]
3. [Ovostat, a low dose oral contraceptive].
Linthorst G; Wolff J
Brux Med; 1970 Jun; 50(6):433-7. PubMed ID: 5487467
[No Abstract] [Full Text] [Related]
4. [Results with the new ovulation inhibitor Ovostat].
Lohmeyer H; Loch EG
Praxis; 1969 Oct; 58(40):1266-71. PubMed ID: 5394570
[No Abstract] [Full Text] [Related]
5. [Clinical study of a mestranol lynestrenol combination of 1 mg. (preliminary report)].
Mateos Cándano M; Bolio Arizta R
Ginecol Obstet Mex; 1969 Jun; 25(152):647-53. PubMed ID: 5372809
[TBL] [Abstract][Full Text] [Related]
6. [Experiences with the normophasic ovulation inhibitor Ovanon].
Nadjafi C
Schweiz Z Gynakol Geburtshilfe; 1971; 2(3):237-44. PubMed ID: 12276413
[TBL] [Abstract][Full Text] [Related]
7. [Trial of a new low-dose anti-ovulation contraceptive].
Bayot D
Schweiz Rundsch Med Prax; 1970 Apr; 59(16):593-7. PubMed ID: 5519719
[No Abstract] [Full Text] [Related]
8. Use of a low-dose oral contraceptive preparation: report of a study.
Koetsawang S; Srisupandit S; Srivanaboon S; Bhiraleus P; Rajawatana D; Kiriwat O
Mod Med Asia; 1975 Oct; 11(10):8-11. PubMed ID: 12279249
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of a new oral contraceptive: ovostat].
Callaerts J; Demol R; Figoureux J; Kock E; Huyghebaert G
Brux Med; 1973 Jul; 53(7):409-18. PubMed ID: 4582059
[TBL] [Abstract][Full Text] [Related]
10. [Oral contraception and gynecologic therapy].
Käsemann W
Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with hormonal suppression of ovulation using the sequential method with chlormadinone acetate and mestranol in different dosage].
Heinen G
Med Welt; 1969 Nov; 44():2420-6. PubMed ID: 5374595
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with the 22-day use (so-called "Friday method") of oral progestagens for contraception].
Szontágh FE; Sas M
Zentralbl Gynakol; 1966 Oct; 88(43):1486-8. PubMed ID: 5995429
[No Abstract] [Full Text] [Related]
13. Ovanon. A new sequential oral contraceptive.
Rice-Wray E; Peña A; Maqueo M
Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
[No Abstract] [Full Text] [Related]
14. Inhibition of ovulation by estrogens.
Gual C; Becerra C; Rice-Wray E; Goldzieher JW
Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
[No Abstract] [Full Text] [Related]
15. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
16. [Management of dysfunctional bleeding as well as hyper- and polymenorrheas using high doses of ovulation inhibitors].
Soergel W
Geburtshilfe Frauenheilkd; 1969 Feb; 29(2):159-65. PubMed ID: 5386827
[No Abstract] [Full Text] [Related]
17. Newer synthetic progestins for the treatment of endometriosis.
Kistner RW
Prog Gynecol; 1970; 5():283-302. PubMed ID: 12332429
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen content of oral contraceptives and thromboembolism.
McQueen EG
N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982
[No Abstract] [Full Text] [Related]
19. [Normal phase method with cyclic administration].
De Cooman SE; Walckiers R; Ferin J
Brux Med; 1971 Mar; 51(3):203-11. PubMed ID: 5578821
[TBL] [Abstract][Full Text] [Related]
20. [The cytohormonal diagnosis under various oral contraceptives].
Loch EG; Tenhaeff D; Lohmeyer H
Z Geburtshilfe Gynakol; 1970; 172(3):261-6. PubMed ID: 12156325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
